Years of potential life lost for brain and CNS tumors relative to other cancers in adults in the United States, 2010

Neuro-Oncology

Volumn 18, Issue 1, 2016, Pages 70-77

  Rouse, Chaturia ^a   Gittleman, Haley ^a,b   Ostrom, Quinn T ^a,b   Kruchko, Carol ^b   Barnholtz Sloan, Jill S ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Central Brain Tumor Registry of the United States   (United States)

Author keywords

CBTRUS; central nervous system tumors; NCHS; years of potential life lost

Indexed keywords

ADULT; AGED; ARTICLE; BLACK PERSON; BRAIN CANCER; BREAST CANCER; BRONCHUS CANCER; CANCER MORTALITY; CAUCASIAN; CENTRAL NERVOUS SYSTEM TUMOR; COLORECTAL CANCER; FEMALE; HISPANIC; HUMAN; LIFE EXPECTANCY; LIFE TABLE; LIFESPAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PROSTATE CANCER; RACE DIFFERENCE; SEX DIFFERENCE; UNITED STATES; VERY ELDERLY; VITAL STATISTICS; YEARS OF POTENTIAL LIFE LOST; BRAIN NEOPLASMS; BREAST NEOPLASMS; CENTRAL NERVOUS SYSTEM NEOPLASMS; FACTUAL DATABASE; INCIDENCE; MIDDLE AGED; MORTALITY; NEOPLASMS; PANCREATIC NEOPLASMS; SURVIVAL ANALYSIS; SURVIVAL RATE; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; BREAST NEOPLASMS; CENTRAL NERVOUS SYSTEM NEOPLASMS; DATABASES, FACTUAL; FEMALE; HUMANS; INCIDENCE; LIFE EXPECTANCY; MALE; MIDDLE AGED; NEOPLASMS; PANCREATIC NEOPLASMS; SEX FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; UNITED STATES; YOUNG ADULT;

EID: 84960424772     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/nov249     Document Type: Article

References (13)

1. Siegel R, Miller K, Jemal A. Cancer statistics, 2015. Ca Cancer J Clin. 2015;65(1):5-29.
2. Heron M. Deaths: leading causes for 2010. Natl Vital Stat Rep. 2013;62(6):1-96.
3. Ostrom QT, Gittleman HR, Liao PL, et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. Neuro-Oncology. 2014; 16(Suppl 4):iv1-iv63.
4. Gittleman HR, Ostrom QT, Rouse CD, et al. Trends in central nervous system tumor incidence relative to other common cancers in adults, adolescents, and children in the United States, 2000 to 2010. Cancer. 2015;121(1):102-112.
5. Gardner JW, Sanborn JS. Years of potential life lost (YPLL)-what does it measure?. Epidemiology. 1990;1(4):322-329.
6. World Health Organization. ICD-10 Classifications of Mental and Behavioral Disorder: Clinical Descriptions and Diagnostic Guidelines. Geneva: World Health Organization; 1992.
7. Ekwueme DU, Chesson HW, Zhang KB, et al. Years of potential life lost and productivity costs because of cancer mortality and for specific cancer sites where human papillomavirus may be a risk factor for carcinogenesis-United States, 2003. Cancer. 2008; 113(S10):2936-2945.
8. Hanly P, Soerjomataram I, Sharp L. Measuring the societal burden of cancer: the cost of lost productivity due to premature cancer-related mortality in Europe. Int J Cancer. 2015;136(4): E136-E145.
9. Liu PH, Wang JD, Keating NL. Expected years of life lost for six potentially preventable cancers in the United States. Prev Med. 2013;56(5):309-313.
10. Gravena AA, Brischiliari SC, Gil LM, et al. Years of potential life lost due to breast and cervical cancer: a challenge for Brazilian public policy. Asian Pac J Cancer Prev. 2014;15(23):10313-10317.
11. Li C, Ekwueme DU. Years of potential life lost caused by prostate cancer deaths in the United States-projection from 2004 through 2050. Cancer Epidemiol. 2010;34(4):368-372.
12. Lariscy JT, Hummer RA, Hayward MD. Hispanic older adultmortality in the United States: new estimates and an assessment of factors shaping the Hispanic paradox. Demography. 2015;52(1):1-14.
13. Burnet NG, Jefferies SJ, Benson RJ, Hunt DP, Treasure FP. Years of life lost (YLL) from cancer is an important measure of population burden-And should be considered when allocating research funds. Br J Cancer. 2005;92(2):241-245.